// App-Quantinova.ai

1435O_PR : Comparison of the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) in clinical trials supporting US Food and Drug Administration (FDA) approval of orphan vs. non-orphan drugs

Researchers

Presenter

  • C. MoltoValiente

Principal Investigators

  • A.Tibau

  • A. OcanaFernandez

  • A.Templeton

  • L.del Carpio Huerta

  • J.Del Paggio

  • A.Barnadas

  • C.Booth

  • E.Amir

Medical Centers

  • Oncology Department, Hospital de la Santa Creu i Sant Pau and Universitat Autonoma de Barcelona, Barcelona, Spain

  • Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain

  • Department of Medical Oncology, St. Claraspital and Faculty of Medicine, University of Basel, Basel, Switzerland

  • Division of Cancer Care and Epidemiology, Queens University Cancer Research Institute, Kingston, ON, Canada

  • Departments of Oncology and Public Health Sciences, Queen’s University Cancer Research Institute, Kingston, ON, Canada

  • Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto, Toronto, ON, Canada

Locations

  • Spain

  • Switzerland

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved